Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations
Abstract Background While mainly larger hospitals have introduced routine anti-Xa assays for rivaroxaban (RXA), these are not readily available to smaller hospitals often relying on routine coagulation tests such as prothrombin time (PT) and activated partial thromboplastin time (aPTT). The aim of o...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2019-11-01
|
| Colecção: | Perioperative Medicine |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s13741-019-0128-9 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|